Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccines: recent developments and future possibilities.

Margaret A Liu1, Britta Wahren, Gunilla B Karlsson Hedestam

  • 1Transgene, Strasbourg, Cedex 67082, France.

Human Gene Therapy
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex.

Nature·2026
Same author

Structural and immunogenetic signatures guide CD4-mimetic HIV vaccine development.

Cell reports·2026
Same author

Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies.

Immunity·2026
Same author

Ultra-high-throughput IGH genotyping of 25 global populations reveals population-biased allelic diversity and homozygous V and D gene deletions.

Immunity·2026
Same author

The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients.

Clinical & translational immunology·2026
Same author

Population-level genomic analysis of immunoglobulin loci variation in rhesus macaques reveals extensive germline diversity.

Immunity·2026
Same journal

Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational Perspectives.

Human gene therapy·2026
Same journal

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration.

Human gene therapy·2026
Same journal

Hyperthermia-Enhanced Adeno-Associated Virus Gene Therapy: Mechanisms, Delivery Technologies, and Translational Potential.

Human gene therapy·2026
Same journal

Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory Meetings.

Human gene therapy·2026
Same journal

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same journal

<i>In Vivo</i> Genome Editing Approach to Disrupt Hydroxyacid Oxidase 1 for the Treatment of Primary Hyperoxaluria Type 1.

Human gene therapy·2026
See all related articles

New DNA vaccine strategies are improving immune responses and showing promise for emerging infectious diseases. These advancements include genetic adjuvants and viral replicons, with some DNA vaccines progressing into clinical trials.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • DNA vaccines represent a rapidly evolving field with ongoing research into enhancing their effectiveness.
  • Current strategies focus on improving immunogenicity, with many studies in preclinical development, while some advance to clinical trials.

Purpose of the Study:

  • To review recent advancements in DNA vaccine technology aimed at increasing immunogenicity.
  • To discuss the potential application of DNA vaccines against emerging infectious agents.
  • To explore the use of DNA vaccines in targeting self-antigens for therapeutic purposes.

Main Methods:

  • Review of recent scientific literature on DNA vaccine development.
  • Analysis of strategies such as genetic adjuvants and viral replicons.

Related Experiment Videos

  • Discussion of clinical trial progress and applications in infectious and autoimmune diseases.

    • Main Results:

    • Several novel strategies, including genetic adjuvants and viral replicons, are being evaluated to boost DNA vaccine immunogenicity.
    • DNA vaccines show potential for addressing emerging infectious diseases due to their adaptability.
    • Applications for targeting self-antigens are also being explored.

    Conclusions:

    • Ongoing research is yielding promising strategies to enhance DNA vaccine efficacy.
    • DNA vaccines offer a flexible platform for combating emerging infectious threats and potentially treating autoimmune conditions.